Daxor Long Term Debt 2010-2011 | DXR

Daxor long term debt from 2010 to 2011. Long term debt can be defined as the sum of all long term debt fields.
Daxor Annual Long Term Debt
(Millions of US $)
2011 $0
2010 $0
2009 $0
Daxor Quarterly Long Term Debt
(Millions of US $)
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.049B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.848B 18.01
DaVita (DVA) United States $10.960B 15.41
Encompass Health (EHC) United States $10.853B 23.01
Elanco Animal Health (ELAN) United States $7.410B 15.87
Chemed (CHE) United States $6.886B 21.64
Option Care Health (OPCH) United States $4.862B 21.67
RadNet (RDNT) United States $4.307B 273.38
Amedisys (AMED) United States $3.214B 21.62
Addus HomeCare (ADUS) United States $2.013B 22.11
LifeStance Health (LFST) United States $1.610B 0.00
Astrana Health (ASTH) United States $1.305B 32.32
U.S Physical Therapy (USPH) United States $1.128B 29.12
Pennant (PNTG) United States $0.805B 29.56
Aveanna Healthcare Holdings (AVAH) United States $0.773B 44.00
Atai Life Sciences (ATAI) Germany $0.715B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.037B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00